Serra Lem Asangbeh

Tafadzwa Dhokotera1,2,3, Serra Asangbeh2,3, Julia Bohlius3,4,5, Elvira Singh1,6, Matthias Egger5,7,8, Eliane Rohner5, Jabulani Ncayiyana6,9, Gary M Clifford10, Victor Olago1,6 and Mazvita Sengayi-Muchengeti1,6,11 1National Cancer Registry, National Health Laboratory Science, 1 Modderfontein Road, Sandringham, Johannesburg 2192, South Africa 2Graduate School for Cellular and Biomedical Sciences, University of Bern, Uni Mittelstrasse, Mittelstrasse 43, CH-3012 Bern, Switzerland 3Swiss Tropical...

Following a global summit in 2015, WHO launched the global programme against hepatitis with the following goals, by 2030, to reduce by 90% the number of new cases of hepatitis B, reduce by 65% the number of hepatitis B-related deaths and treat 80% of eligible people infected with hepatitis B. 8 The systematic review and meta-analysis published in Lancet by Schweitzer and colleagues in 2015 provides the global prevalence of HBV with estimate by countries.

We initially identified 4036 records. After elimination of duplicates, 3619 records remained. We screened the titles and abstracts and excluded 3558 irrelevant records. Agreement between investigators on abstract selection was ?=0·78. We scrutinised full texts of the remaining 61 papers for eligibility, of which 31 were excluded (figure 1figure 1).25x25Abbara, A, Chatterjee, B, Thomson, E, Main, J, and Cooke, G. Trends in respiratory presentation over 10 years in a single-centre HIV-positive cohort.